Health Occupations - Cross-Sex Hormone Therapy for Minors

HB 679 prohibits licensed healthcare providers in Maryland from prescribing, dispensing, or administering cross-sex hormone treatments (including estrogen, testosterone, or blockers) for the purpose of treating gender-related mental health conditions like gender dysphoria in minors. The bill directly affects minors under 18 seeking such treatment and healthcare practitioners who would provide it. Violating this law is classified as a felony, punishable by up to life imprisonment. The law takes effect October 1, 2026, and defines "cross-sex hormone therapy" as treatment to develop secondary sex characteristics for gender transition.